1 2007 Vol: 51(1). DOI: 10.1590/S0004-27302007000100022

Auto-imunidade ANCA (Anticorpo Anti-Citoplasma de Neutrófilos) positiva induzida por propiltiouracil: relato de caso e revisão da literatura

Antithyroid drugs sometimes cause severe complications. Propylthiouracil (PTU) can be associated to ANCA positive vasculitis, most often related to myeloperoxidase subtype (ANCA-MPO). Our objective is to describe a female patient with Graves' disease, who developed PTU induced-autoimmune disease, with cutaneous, pulmonary, and renal lesions, associated with ANCA. Histopathological examination revealed diffuse pulmonary hemorrhage, and focal segmental glomerulosclerosis at the kidney biopsy. She was treated with systemic corticosteroid therapy and cyclophosphamide, with clinical improvement. This case highlights the need for greater awareness of this relatively rare adverse effect of propylthiouracil. 

Mentions
Figures
Figure 1 Figure 2
Altmetric
References
  1. Sato H, Hattori M, Fujieda M, Sugihara A, Inomata H, Hoshi M, et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab85 , 4270-3 (2000) .
  2. Gaburri PD, Chebli JMF, Attalla A, Pereira CMN, Bonfante HL, Martins-junior EV, et al. Colonic ulcers in propylthiouracil induced vasculitis with secondary antiphospholipid syndrome. Postgrad Med J81 , 338-40 (2005) .
  3. Slot M, Links TP, Stegeman CA, Tervaert JWC. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term follow-up study. Arthritis Rheum53 , 108-13 (2005) .
  4. Choi HK, Merkel PA, Walker AM, Niles JL. Drug associated antineutrophil cytoplasmic antibody positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum43 , 405-13 (2000) .
  5. Vanek C, Samuels MH. Central nervous system vasculitis caused by propylthiouracil therapy: a case report and literature review. Thyroid15 , 80-4 (2005) .
  6. Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bikilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther7 , 1072-81 (2005) .
  7. Gao Y, Ye H, Yu F, Guo X-H, Zhao M-H. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies vasculitis. Clin Immunology117 , 87-93 (2005) .
  8. Guma M, Salina S, Reverter JL, Roca J, Valls-Roc M, Juan M, et al. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole. J Clin Endocrinol88 , 3141-6 (2003) .
  9. Morita S, Ueda Y, Eguchi K. Anti-thyroid drug induced ANCA associated vasculitis: a case report and review of the literature. Endocr J47 , 467-70 (2000) .
  10. Thamprajamchit S, Jariengprasert C, Rajatanavin R. Propylthiouracil-induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies. Endocr Pract10 , 432-7 (2004) .
  11. Gunton JE, Stiel J, Caterson RJ, McElduff A. Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J Clin Endocrinol Metab84 , 13-6 (1999) .
  12. Dhillon SS, Singh D, Doe N, Qadri AM, Ricciardi S, Schwarz MI. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Chest116 , 1485-8 (1999) .
  13. Tsai MH, Chang YL, Wu VC, Chang CC, Huang TS. Methimazole induced pulmonary hemorrhage associated with antimyeloperoxidase antineutrophil cytoplasmic autoantibody: a case report. J Formos Med Assoc100 , 772-5 (2001) .
  14. Yamauchi K, Sata M, Machiya J, Osaka D, Wada T, Abe S, et al. Antineutrophil cytoplasmic autoantibody positive alveolar hemorrhage during propylthiouracil therapy for hyperthyroidism. Respirology8 , 532-5 (2003) .
  15. Ohwada R, Kato K, Ohmori K, Isosaki O, Hotta M, Ono M, et al. A man with interstitial pneumonia due to propylthiouracil. Inter Med42 , 1026-30 (2003) .
  16. Nakamoro Y, Tominaga T, Inoue Y, Shinohara K. Propylthiouracil induced associated with antineutrophil antibody against myeloperoxidase. Inter Med42 , 463-4 (2003) .
  17. Vazel-Boulenger A, Kupfer-Bessaguet I, Gouedard C, Leberre R, Leroy JP, Sonnet E, et al. Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA. Ann Dermatol Venereolol132 , 27-31 (2005) .
  18. Jacobs EM, Hartkemp A, Kaasjager HA. PTU associated cutaneus vasculitis with ANCA anti-MPO and anti PR3 antibodies. Neth J Med61 , 296-9 (2003) .
  19. Hong SB, Lee MH. A case of propylthiouracil induced pyoderma gangrenosum associated with antineutrophil cytoplasmic autoantibody. Dermatology208 , 339-41 (2004) .
  20. Kudoh Y, Kuroda S, Shimamoto K, Iimura O. Propylthiouracil induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol48 , 41-3 (1997) .
  21. Kitara T, Hiromura K, Maezawa A, Ono K, Narabara N, Yano S, et al. Case of propylthiouracil induced vasculitis associated with antineutrophil cytoplasmic antibodies; review of literature. Clin Neprhol47 , 336-40 (1997) .
  22. Winters MJ, Hurley RM, Lirenman DS. ANCA positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil. Pediatr Nephrol17 , 257-60 (2002) .
  23. Yamada A, Sato K, Tochimoto A, Takagi S, Hizuka N, Takano K. Propylthiouracil induced lupus-like syndrome developing in a Graves patient with a sibling with systemic lupus erytematosus. Intern Med41 , 1204-8 (2002) .
  24. Ye H, Guo X-H, Zhao M-H, Gao Y, Zhang Y, Gao Y. Epitope mapping of myeloperoxidades antibodies in propylthiouracil-induced vasculitis and microscopic polyangiitis. Zhonghua Nei Ke ZA ZHI43 , 915-9 (2004) .
  25. Noh JY, Asari T, Hamada N, Ishikawa N, Abes H, Ito K. Frequency of appearance of myeloperoxidades-antineutrophil cytoplasmic antibodies (MPO-ANCA) in Graves's disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol54 , 651-4 (2001) .
  26. Yu F, Zhao Mh, Zhang YK, Zhang Y, Wang HY. Anti-endothelial cell antibodies with propylthiouracil-induced ANCA positive vasculitis are associated with disease activity. Clin Exp Immunol139 , 569-74 (2005) .
  27. Gunton JE, Clifton-Bligh P, Wilmshurst E, McEldulff A. Prevalence of antineutrophil cytoplasmic antibody in patients receiving anti-thyroid medication. Eur J Endocrinol142 , 587-90 (2000) .
  28. Fujieda M, Hatori M, Kurayama H. Clinical features and outcomes with antineutrophil cytoplasmic auto antibody positive glomerulonephritis with on propylthiouracil treatment. J Am Soc Nephrol13 , 437-45 (2002) .
  29. Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves disease. Thyroid10 , 595-9 (2000) .
  30. Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough C, et al. Propylthiouracil and carbimazole associated antineutrophil cytoplasmic antibodies in Patients with Graves's disease. Clin Endocrinol60 , 671-5 (2004) .
  31. Wada N, Mukai M, Kohno M, Notoya A, Ito T, Yoshioka N. Prevalence of serum anti-myeloperoxidades antineutrophil cytoplasmic antibodies in patients with Graves's disease treated with propylthiouracil and thiamazole. Endocr J49 , 329-34 (2002) .
Expand